Notice of Intent to Award to Sole Source Fse Tender - 141324080

Procurement Summary

Country: USA

Summary: Notice of Intent to Award to Sole Source Fse Onsite Annual Preventative Maintenance

Deadline: 29 May 2026

Posting Date: 15 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 141324080

Document Ref. No.: 97963

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to CEPHEID.
This contract action is being conducted in accordance with FAR Overhaul Part 12.102, Restricting Competition. The Government determined that only one source is reasonably available to meet the current requirement based on the proprietary nature of the existing system configuration, compatibility requirements, and continuity of ongoing operations. The North American Industry Classification System code for this procurement is 325413 - In-Vitro Diagnostic Substance Manufacturing. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive proposals; however, all responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist Ruben Reyes at [email protected] by 08:00AM, May 29, 2026.
The Government currently utilizes the Cepheid GeneXpert DX system, an automated platform used for rapid detection and analysis of carbapenemase gene markers from rectal swab specimens and wastewater samples in support of public health testing activities.
The GeneXpert DX system has been integrated into the existing laboratory workflow and supports continuity of operations, surge testing capabilities, and ongoing Healthcare Wastewater sampling efforts. The system is also used to support comparative analysis against standard PCR testing methodologies.
Due to the proprietary nature of the GeneXpert DX platform, including manufacturer-specific components, s...
Notice ID: 97963

Department/Ind. Agency: health and human services, department of

Sub-tier: centers for disease control and prevention

Office: cdc office of acquisition services

Product Service Code: j066 - maint/repair/rebuild of equipment- instruments and laboratory equipment

NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Inactive Dates: jun 13, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice